JAZZ financials
Jazz Pharmaceuticals (JAZZ) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
JAZZ income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $4.27B | $3.76B | $224.42M | -$356.15M | -5.84 |
| 2024 | $4.07B | $3.62B | $716.63M | $560.12M | 8.65 |
| 2023 | $3.83B | $3.40B | $578.58M | $414.83M | 6.10 |
| 2022 | $3.66B | $3.12B | -$65.53M | -$224.06M | -3.58 |
| 2021 | $3.09B | $2.65B | $170.28M | -$328.95M | -5.51 |
| 2020 | $2.36B | $2.21B | $378.07M | $238.62M | 4.22 |
- JAZZ revenue was $4.27B in fiscal 2025, net income -$356.15M.
Updated 2026-11-02 23:14 UTC